Skip to main content
Bo Shen, MD, Gastroenterology, New York, NY, New York-Presbyterian Hospital

BoShenMD

Gastroenterology New York, NY

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Director, Inflammatory Bowel Disease Center

Overview of Dr. Shen

Dr. Bo Shen is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Other and has been in practice 40 years. He is one of 109 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 299 doctors at New York-Presbyterian Hospital who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Gastroenterology, 1998 - 2001
  • Carle Foundation Hospital
    Carle Foundation HospitalResidency, Internal Medicine, 1995 - 1998
  • Other
    OtherClass of 1982
  • Nanjing University
    Nanjing UniversityClass of 1982

Certifications & Licensure

  • CT State Medical License
    CT State Medical License Current
  • FL State Medical License
    FL State Medical License 2020 - Present
  • OH State Medical License
    OH State Medical License 2000 - 2026
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2019 - 2025
  • IL State Medical License
    IL State Medical License 1995 - 1998

Publications & Presentations

PubMed

Press Mentions

  • Sigma-1 Receptor Ligands Improves Ventricular Repolarization-Related Ion Remodeling in Rats with Major Depression Disorder
    Sigma-1 Receptor Ligands Improves Ventricular Repolarization-Related Ion Remodeling in Rats with Major Depression DisorderNovember 2nd, 2020
  • Median Pay for NY-Area Hospital CEOs Tops $1.1M
    Median Pay for NY-Area Hospital CEOs Tops $1.1MJanuary 16th, 2020
  • Confirmed: TNF Inhibitors Don't Raise Cancer Risk
    Confirmed: TNF Inhibitors Don't Raise Cancer RiskDecember 13th, 2019
  • Join now to see all

Hospital Affiliations